Myron W. Wentz Sells 100,000 Shares of USANA Health Sciences, Inc. (USNA) Stock

USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 100,000 shares of USANA Health Sciences stock in a transaction that occurred on Friday, May 25th. The shares were sold at an average price of $115.00, for a total transaction of $11,500,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

USANA Health Sciences opened at $112.60 on Friday, according to Marketbeat.com. The company has a market capitalization of $2.83 billion, a price-to-earnings ratio of 27.73 and a beta of 0.76. USANA Health Sciences, Inc. has a 12-month low of $52.80 and a 12-month high of $121.15.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings data on Tuesday, April 24th. The company reported $1.19 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.05 by $0.14. USANA Health Sciences had a net margin of 6.47% and a return on equity of 27.92%. The business had revenue of $292.00 million during the quarter, compared to analysts’ expectations of $268.93 million. During the same period in the previous year, the company earned $0.91 earnings per share. USANA Health Sciences’s revenue for the quarter was up 14.4% on a year-over-year basis. equities research analysts predict that USANA Health Sciences, Inc. will post 4.4 EPS for the current fiscal year.



Several institutional investors have recently modified their holdings of the company. Renaissance Technologies LLC lifted its stake in shares of USANA Health Sciences by 0.7% in the fourth quarter. Renaissance Technologies LLC now owns 1,930,966 shares of the company’s stock worth $142,988,000 after buying an additional 12,700 shares during the last quarter. BlackRock Inc. lifted its stake in shares of USANA Health Sciences by 14.2% in the first quarter. BlackRock Inc. now owns 829,290 shares of the company’s stock worth $71,237,000 after buying an additional 103,325 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of USANA Health Sciences by 1.9% in the first quarter. Dimensional Fund Advisors LP now owns 777,313 shares of the company’s stock worth $66,771,000 after buying an additional 14,692 shares during the last quarter. Teachers Advisors LLC lifted its stake in shares of USANA Health Sciences by 1.2% in the fourth quarter. Teachers Advisors LLC now owns 211,824 shares of the company’s stock worth $15,686,000 after buying an additional 2,506 shares during the last quarter. Finally, Matarin Capital Management LLC acquired a new stake in shares of USANA Health Sciences in the first quarter worth $13,476,000. Institutional investors and hedge funds own 48.85% of the company’s stock.

A number of analysts have issued reports on USNA shares. Pivotal Research lifted their target price on shares of USANA Health Sciences from $80.00 to $95.00 and gave the company a “buy” rating in a research note on Wednesday, February 7th. TheStreet cut shares of USANA Health Sciences from a “b+” rating to a “c+” rating in a research note on Tuesday, February 6th. Finally, ValuEngine upgraded shares of USANA Health Sciences from a “hold” rating to a “buy” rating in a research note on Wednesday, May 2nd. One research analyst has rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $95.00.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply